The experimental vaccine has not yet undergone human clinical trials, but in four preclinical animal trials, the pan-fungal vaccine led to the development of antibodies. The research team is planning a phase 1 human study, according to a Jan. 31 report from the Athens, Ga.-based university.
Zero approved fungal vaccines exist even though fungal infections kill 1.5 million people every year and double hospitalization costs, the university said.
“Because it targets three different pathogens, the vaccine has the potential to be groundbreaking regarding invasive fungal infections,” Karen Norris, PhD, the lead investigator, said. “We believe this is a very strong vaccine candidate.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
